Research location

Alzira

Spain

Published trials53

Site observations53

Linked trials published53

Page1 / 2

Research activity in Alzira

Spain

CureCurrent currently publishes aggregate city-level research activity for this location: 53 trials and 53 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Alzira

53 linked trials · page 1 of 2

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20 · 1 site observation

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesNCT07282600 · 2025-12-15 · 1 site observation

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationNCT06959095 · 2025-06-20 · 1 site observation

DESTINY Breast Respond HER2-(Ultra)Low EuropeNCT05945732 · 2023-10-24 · 1 site observation

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951 · 2023-03-31 · 1 site observation

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03 · 1 site observation

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 1 site observation

ACTIVE_NOT_RECRUITING

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisNCT04631016 · 2020-12-14 · 1 site observation

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBCNCT04408118 · 2020-10-05 · 1 site observation

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelNCT04133909 · 2019-10-30 · 1 site observation

Tezepelumab COPD Exacerbation StudyNCT04039113 · 2019-07-30 · 1 site observation

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsNCT03115112 · 2017-10-12 · 1 site observation

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodNCT02787551 · 2016-07-06 · 1 site observation

Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)NCT02465567 · 2015-06-30 · 1 site observation

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)NCT02335957 · 2015-04-01 · 1 site observation

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsNCT02320721 · 2015-01-01 · 1 site observation

A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesNCT02152371 · 2014-05-01 · 1 site observation

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusNCT01989754 · 2014-01-16 · 1 site observation

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesNCT02058160 · 2014-01-01 · 1 site observation

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsNCT01798706 · 2013-06-01 · 1 site observation

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesNCT01790438 · 2013-03-01 · 1 site observation

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesNCT01719003 · 2012-10-01 · 1 site observation

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesNCT01624259 · 2012-06-01 · 1 site observation

A Study of LY2605541 in Participants With Type 2 Diabetes MellitusNCT01582451 · 2012-05-01 · 1 site observation

A Study in Participants With Type I Diabetes MellitusNCT01454284 · 2012-01-01 · 1 site observation

A Study in Patients With Type 2 DiabetesNCT01408095 · 2011-09-01 · 1 site observation

Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)NCT01394952 · 2011-07-22 · 1 site observation

A Study of LY2409021 in Patients With Type 2 DiabetesNCT01241448 · 2011-01-01 · 1 site observation

A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01 · 1 site observation

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesNCT01029886 · 2010-01-01 · 1 site observation

A Study of LY2599506 in Patients With Type 2 DiabetesNCT01024244 · 2009-12-01 · 1 site observation

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineNCT00976391 · 2009-09-01 · 1 site observation

A Dose-Finding Study of RO4998452 in Patients With Diabetes MellitusNCT00800176 · 2009-01-22 · 1 site observation

Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesNCT00791479 · 2008-12-01 · 1 site observation

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)NCT00765830 · 2008-09-01 · 1 site observation

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusNCT00700817 · 2008-06-01 · 1 site observation

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)NCT00677807 · 2008-05-01 · 1 site observation

A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)NCT00622635 · 2008-01-01 · 1 site observation

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.NCT00502710 · 2007-07-01 · 1 site observation

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesNCT00469092 · 2007-05-01 · 1 site observation

Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesNCT00348712 · 2006-10-30 · 1 site observation

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes MellitusNCT00391209 · 2006-10-01 · 1 site observation

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesNCT00355849 · 2006-08-01 · 1 site observation

Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaNCT00320489 · 2006-04-01 · 1 site observation

The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)NCT00279201 · 2005-12-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.